PL1740164T3 - Statyny do leczenia nadciśnienia śródgałkowego i jaskry - Google Patents

Statyny do leczenia nadciśnienia śródgałkowego i jaskry

Info

Publication number
PL1740164T3
PL1740164T3 PL05738648T PL05738648T PL1740164T3 PL 1740164 T3 PL1740164 T3 PL 1740164T3 PL 05738648 T PL05738648 T PL 05738648T PL 05738648 T PL05738648 T PL 05738648T PL 1740164 T3 PL1740164 T3 PL 1740164T3
Authority
PL
Poland
Prior art keywords
statins
glaucoma
treatment
ocular hypertension
coa reductase
Prior art date
Application number
PL05738648T
Other languages
English (en)
Inventor
Mark R Hellberg
Debra L Fleenor
Allan Shepard
Iok-Hou Pang
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PL1740164T3 publication Critical patent/PL1740164T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
PL05738648T 2004-04-26 2005-04-25 Statyny do leczenia nadciśnienia śródgałkowego i jaskry PL1740164T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56546904P 2004-04-26 2004-04-26
EP05738648A EP1740164B1 (en) 2004-04-26 2005-04-25 Statins for the treatment of ocular hypertension and glaucoma
PCT/US2005/014255 WO2005105069A1 (en) 2004-04-26 2005-04-25 Statins for the treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
PL1740164T3 true PL1740164T3 (pl) 2009-01-30

Family

ID=34966865

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05738648T PL1740164T3 (pl) 2004-04-26 2005-04-25 Statyny do leczenia nadciśnienia śródgałkowego i jaskry

Country Status (20)

Country Link
US (2) US20050239871A1 (pl)
EP (1) EP1740164B1 (pl)
JP (1) JP2007534699A (pl)
KR (2) KR20110091600A (pl)
CN (1) CN1946384B (pl)
AT (1) ATE404189T1 (pl)
AU (1) AU2005237543B2 (pl)
BR (1) BRPI0510245A (pl)
CA (1) CA2560167A1 (pl)
CY (1) CY1108490T1 (pl)
DE (1) DE602005008935D1 (pl)
DK (1) DK1740164T3 (pl)
ES (1) ES2311986T3 (pl)
HK (1) HK1102913A1 (pl)
MX (1) MXPA06012225A (pl)
PL (1) PL1740164T3 (pl)
PT (1) PT1740164E (pl)
SI (1) SI1740164T1 (pl)
WO (1) WO2005105069A1 (pl)
ZA (1) ZA200607988B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415364B2 (en) * 2003-11-26 2013-04-09 Duke University Method of preventing or treating glaucoma
KR20080082618A (ko) * 2005-12-16 2008-09-11 알콘, 인코퍼레이티드 Ａｌｋ5 조절제를 사용한 안압의 조절
AU2007245410A1 (en) 2006-04-26 2007-11-08 Rosemont Pharmaceuticals Ltd Liquid oral compositions
US20090202524A1 (en) * 2007-10-31 2009-08-13 Alcon Research, Ltd. Pai-1 expression and activity inhibitors for the treatment of ocular disorders
ES2330184B1 (es) * 2008-06-03 2010-07-05 Neuron Biopharma, S.A. Uso de estatinas como anticonvulsivantes, antiepilepticos y neuroprotectores.
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
CN102093984B (zh) * 2010-11-23 2012-07-04 清华大学 一种杂合酶P450sca2-BMR及其编码基因与应用
AU2013214693B2 (en) * 2012-02-02 2017-02-23 Kenneth Gek-Jin OOI Improvements in tear film stability
GB201611782D0 (en) * 2016-07-06 2016-08-17 Optibiotix Ltd Composition
US10696638B2 (en) 2017-12-26 2020-06-30 Industrial Technology Research Institute Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2585708B1 (fr) * 1985-07-31 1989-07-07 Sanofi Sa Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique
US5151444B1 (en) * 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
EP0569046B1 (en) * 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
FR2647675B1 (fr) * 1989-06-05 1994-05-20 Sanofi Utilisation d'un derive de la statine dans le traitement des affections oculaires
JPH04243835A (ja) * 1990-08-29 1992-08-31 Pfizer Inc 高眼圧症又は緑内障治療用薬剤組成物及び治療方法
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US6586425B2 (en) * 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US6569461B1 (en) * 1999-03-08 2003-05-27 Merck & Co., Inc. Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
WO2002024194A2 (en) * 2000-09-19 2002-03-28 Novimmune S.A. Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
US20030065020A1 (en) * 2001-07-13 2003-04-03 Catharine Gale Treatment of macular degeneration
US20030195167A1 (en) * 2002-04-15 2003-10-16 Kowa Co., Ltd. PTX3-gene expression inhibitor
JP2004149480A (ja) * 2002-10-31 2004-05-27 Saisentan Igaku Kenkyusho:Kk 経口又は経皮投与用の眼科疾患治療剤
AU2004247627A1 (en) * 2003-05-16 2004-12-23 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
JP2006526640A (ja) * 2003-05-30 2006-11-24 コンビナトアールエックス インコーポレーティッド 新生物を治療するための併用治療
US8415364B2 (en) * 2003-11-26 2013-04-09 Duke University Method of preventing or treating glaucoma
US20090202524A1 (en) * 2007-10-31 2009-08-13 Alcon Research, Ltd. Pai-1 expression and activity inhibitors for the treatment of ocular disorders

Also Published As

Publication number Publication date
CA2560167A1 (en) 2005-11-10
BRPI0510245A (pt) 2007-10-23
SI1740164T1 (sl) 2009-02-28
CN1946384B (zh) 2011-04-20
WO2005105069A1 (en) 2005-11-10
MXPA06012225A (es) 2007-01-31
DE602005008935D1 (de) 2008-09-25
DK1740164T3 (da) 2008-11-10
ATE404189T1 (de) 2008-08-15
EP1740164A1 (en) 2007-01-10
US20110098314A1 (en) 2011-04-28
KR20110091600A (ko) 2011-08-11
CY1108490T1 (el) 2014-04-09
AU2005237543B2 (en) 2011-02-10
CN1946384A (zh) 2007-04-11
EP1740164B1 (en) 2008-08-13
ES2311986T3 (es) 2009-02-16
AU2005237543A1 (en) 2005-11-10
PT1740164E (pt) 2008-10-21
KR101071192B1 (ko) 2011-10-10
HK1102913A1 (en) 2007-12-07
KR20070007932A (ko) 2007-01-16
JP2007534699A (ja) 2007-11-29
US20050239871A1 (en) 2005-10-27
ZA200607988B (en) 2007-12-27

Similar Documents

Publication Publication Date Title
HK1102913A1 (en) Statins for the treatment of ocular hypertension and glaucoma
WO2006066103A3 (en) Ophthalmic implant for treatment of glaucoma
EA200701134A1 (ru) Средство для профилактики или лечения глаукомы
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
TW200733964A (en) (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions
WO2006071548A3 (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2006044425A3 (en) Ophthalmic compositions for treating ocular hypertension
HK1082668A1 (en) Remedies for glomerular diseases
WO2003072066A3 (en) Compositions and methods for the treatment of glaucoma and ocular hypertension
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
CA2505086A1 (en) Ophthalmic compositions for treating ocular hypertension
WO2005020917A3 (en) Ophthalmic compositions for treating ocular hypertension
AU4672300A (en) Biochemical methods that eliminate corneal scars, opacification and haze
WO2004043354A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2006020003A3 (en) Ophthalmic compositions for treating ocular hypertension
EP1251862A4 (en) ORTHALMOLOGICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR HYPERTENSION
MXPA04006029A (es) Derivados novedosos de benzofuranimidazolina y benzodifuranimidazolina y su uso para el tratamiento de glaucoma.
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
WO2002060339A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2004087051A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2003077845A3 (en) Compositions and methods for treating glaucoma and ocular hypertension